Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
R

Follicular Lymphoma - Next Steps: What is the First-Line Standard in Limited Stage and Advanced Stage (A)Symptomatic Disease?

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Robert Marcus
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Robert Marcus
0 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Recommended

AUTOPLAY
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

Feat. B. D. Cheson
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
17:07
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…

Feat. M. Minnema
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
19:46
Scripps Health

Management of Indolent NHL

Feat. E. Brem
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
08:28
Bruce D. Cheson

Tazemetostat in R/R FL: Impact of EZH2 Mutational Status on PFS

19:20
Mitchell Smith

Treatment Landscape in Follicular Lymphoma

25:23
Indy Hematology Review

When Not to Watch and Wait: Emerging Strategies in the Treatment of …

Feat. M. Williams
08:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzu…

Feat. C. Flowers
19:14
SOHO Brazil 2024

FL: How Do I Deal With Relapse?

Feat. B. Kahl
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
22:38
Indy Hematology Review

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Feat. T. Phillips
15:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Current Clinical Management of Follicular Lymphoma

Feat. B. Ferhanoğlu
14:34
Northwestern Medicine Oncology and Hematology

EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial

Feat. L. Gordon
10:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in…

Feat. R. Merryman